Trizzino John

Avg. Two Year Performance

6% Avg. Purchase Return
3% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)(8%)(3%)23%6%
Purchase Success Rate1 of 42 of 42 of 42 of 42 of 4
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 100 of 100 of 100 of 100 of 10

Novavax, Inc.

Drugs » Biotechnology

EVP, CCO and CBO:

Holdings: 28.31K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--